Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight
Clinical trial NCT04320771 · TERMINATED
Trial details
- NCT number
- NCT04320771
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-02
- Primary completion
- 2018-08-08
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.